Brief: Akari Therapeutics Announces First Patient To Complete Course Of Treatment In The Phase III Part A Clinical Trial Of Investigational Nomacopan
07/07/2022 13:03
July 7 (Reuters) - Akari Therapeutics PLC AKTX.O :
* AKARI THERAPEUTICS ANNOUNCES FIRST PATIENT TO COMPLETE
COURSE OF
TREATMENT IN THE PHASE III PART A CLINICAL TRIAL OF
INVESTIGATIONAL NOMACOPAN IN PEDIATRIC HEMATOPOIETIC STEM CELL
TRANSPLANT-RELATED THROMBOTIC MICROANGIOPATHY (HSCT-TMA)
Source text for Eikon: ID:nGNE2pyRl4
Further company coverage: AKTX.O